<DOC>
	<DOCNO>NCT02582021</DOCNO>
	<brief_summary>The Women 's Ischemia Study Evaluation ( WISE ) , cohort study 1000 woman , make many contribution understand cardiovascular disease . A milestone acknowledge 2011 AHA Herrick Lecture role Coronary Microvascular Dysfunction ( CMD ) woman symptoms/signs ischemia without obstructive coronary artery disease ( CAD ) . While 1996 , CMD consider `` imaging artifact '' , 2013 , widely accept pathophysiologic process require systematic cohesive scientific pursuit . CMD prevalent , associate adverse clinical outcome , poor quality life healthcare cost rival obstructive CAD . There 2-3 million US woman CMD , 100,000 new case project annually place CMD prevalence , morbidity cost higher female reproductive cancer combine . Among woman ischemia , preserve ejection fraction obstructive CAD , observe relatively new onset heart failure ( HF ) hospitalization nonfatal myocardial infarction ( MI ) . It hypothesize CMD contributes leave ventricular ( LV ) diastolic dysfunction subsequent heart failure preserve ejection fraction ( HFpEF ) . Preliminary data suggest leave ventricular diastolic dysfunction link CMD via mechanism augmentation and/or perpetuation cardiomyocyte fat accumulation . HFpEF prevalent woman old men , poorly understood . Mechanistic understanding critical HFpEF intervention guideline development . The study hypotheses follow : 1 . Risk factor condition ( hypertension , dyslipidemia , dysglycemia , loss estrogen ) promote inflammatory pro-oxidative state making microvasculature vulnerable ; 2 . Vulnerable coronary microvasculature become dysregulated ( sympathetic nervous system activation , endothelial dysfunction , change vascular smooth muscle activation , spasm ) causing repeat episode transient ischemia ; 3 . Repeated ischemia-reperfusion episode facilitate precondition preservation cardiomyocyte contractile microvascular function ischemic injury ; 4 . Ischemia-reperfusion precondition lead cardiomyocyte fat accumulation relaxation impairment result diastolic dysfunction heart failure preserve ejection fraction ( HFpEF ) .</brief_summary>
	<brief_title>WISE CVD - Continuation ( WISE HFpEF )</brief_title>
	<detailed_description>The current application study new cohort woman men follow specific aim : Specific Aim 1 : LV diastolic dysfunction link CMD . Sub-Aim 1 : LV diastolic dysfunction CMD link via mechanism cardiomyocyte fat accumulation . Specific Aim 2 : Comprehensive noninvasive Cardiac Magnetic Resonance Imaging ( CMRI ) include LV diastolic function link invasive measure LV diastolic function optimize diagnosis CMD . Sub-Aim 2 : Coronary Magnetic Resonance Angiography ( CMRA ) exclude obstructive CAD CMD . Exploratory Aim : Blood proteomic metabolomics biomarkers extracellular matrix remodel fibrosis combine ischemia measure predict HFpEF . In prospective , cohort design study , investigator intend enroll 220 new subject include 120 symptomatic woman undergo invasive coronary angiography suspect ischemia obstructive coronary artery disease ( CAD ) define ≥50 % luminal diameter stenosis ≥1 epicardial coronary artery 100 woman men hospitalize Heart Failure preserve Ejection Fraction ( HFpEF ) define European Society Cardiology ( ESC ) criterion yet undergone coronary angiography . New exist sample long term follow-up analyzed exploratory fashion look potential HFpEF biomarkers pilot data purpose . After baseline evaluation , n=120 cohort undergo noninvasive high resolution , comprehensive CMRI imaging , invasive angiography , coronary reactivity test rest-stress Millar pressure-volume measurement . Handgrip , mild leg exercise , brief Valsalva Maneuver conduct CMRI Millar pressure-volume assessment characterize cardiac response stress . Lastly , patient also undergo MR Coronary Angiography , validation purpose gold-standard angiography . The cohort 100 woman men HFpEF admit hospital yet undergone coronary angiography also undergo CMRI ( stress ) , include MR coronary angiography ( CMRA ) noninvasive compute coronary tomographic angiography ( CCTA ) ( CSMC ) . This provide understand non-cath-lab base population regard link CMD , diastolic function HFpEF , result data test hypothesis coronary MRA exclude obstructive CAD diagnose CMD without ionize radiation . Proteomic metabolomics biomarker assay ( n=567 ) subject obstructive CAD ( Exploratory Aim ) perform .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>For new cohort n=120 woman undergo coronary angiography : Symptomatic angina anginal equivalent Age ≥ 18 Participant willing give write informed consent For cohort n=100 woman men hospitalize HFpEF ( define ESC guideline ) : Age ≥ 18 Signs symptom heart failure Preserved ejection fraction Structural evidence cardiovascular abnormality : elevate brain naturetic peptide , evidence abnormal filling relaxation , leave ventricular hypertrophy , increase leave atrial size Participant willing give write informed consent For new cohort n=120 woman undergo invasive coronary angiography : Acute coronary syndrome ( defined American College Cardiology/American Heart Association ( ACC/AHA ) guideline ) Acute myocardial infarction Primary valvular heart disease clearly indicate need valve repair replacement Patients concurrent cardiogenic shock require inotropic intraaortic balloon support Left Ventricular Ejection Fraction ( LVEF ) &lt; 50 % Prior plan percutaneous coronary intervention coronary artery bypass graft Noncardiac illness life expectancy &lt; four year Unable give inform consent Chest pain alternative nonischemic etiology , i.e . pericarditis , pulmonary embolism , pleurisy , pneumonia , esophageal spasm , etc . Contraindications CMRI , internal cardiac defibrillator , untreatable claustrophobia know angioedema End stage renal liver disease For new cohort n=100 woman men hospitalize HFpEF : Acute coronary syndrome ( define ACC/AHA guideline ) Acute myocardial infarction Primary valvular heart disease clearly indicate need valve repair replacement Patients concurrent cardiogenic shock require inotropic intraaortic balloon support Prior plan percutaneous coronary intervention coronary artery bypass graft Noncardiac illness life expectancy &lt; four year Unable give inform consent Chest pain alternative nonischemic etiology , i.e . pericarditis , pulmonary embolism , pleurisy , pneumonia , esophageal spasm , etc . Contraindications CMRI , internal cardiac defibrillator , untreatable claustrophobia know angioedema End stage renal liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Microvascular Coronary Dysfunction ( MCD )</keyword>
	<keyword>Magnetic resonance imaging ( MRI )</keyword>
	<keyword>Coronary angiography</keyword>
	<keyword>Coronary Vascular Dysfunction ( CVD )</keyword>
</DOC>